Jpmorgan Chase & CO Biotech Acquisition CO Transaction History

Jpmorgan Chase & CO

$1.1 Trillion
Q1 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 13, 2023	SELL	$9.92 - $10.11 $985,452 - $1 Million	-99,340 Reduced 49.67%	100,660 $1.02 Million
Q3 2022 Nov 14, 2022	SELL	$9.83 - $9.92 $17.9 Million - $18 Million	-1,816,756 Reduced 90.08%	200,000 $1.99 Million
Q2 2022 Aug 11, 2022	BUY	$8.96 - $9.97 $18.1 Million - $20.1 Million	2,016,756 New	2,016,756 $20 Million
Q1 2022 May 11, 2022	SELL	$9.75 - $9.91 $487,500 - $495,500	-50,000 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$9.73 - $9.91 $486,500 - $495,500	50,000 New	50,000 $492,000

Others Institutions Holding BIOT

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Biotech Acquisition Co

Ticker BIOT
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 23,000,000
Description
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

More about BIOT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.